Marathon Asset Management (UK)’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46M	Buy	93,421 +7,875	+9%	+$4.27M	1.76%	21
2025 Q4	$49.6M	Sell	85,546 -7,256	-8%	-$4.1M	1.91%	19
2025 Q3	$45.1M	Sell	92,802 -29,919	-24%	-$13.9M	1.66%	27
2025 Q2	$49.8M	Buy	122,721 +54,086	+79%	+$22.6M	1.6%	24
2025 Q1	$34.2M	Buy	68,635 +4,042	+6%	+$2.19M	1.04%	36
2024 Q4	$33.6M	Sell	64,593 -2,666	-4%	-$1.47M	0.94%	39
2024 Q3	$41.6M	Sell	67,259 -41,725	-38%	-$24.7M	1.15%	32
2024 Q2	$60.3M	Sell	108,984 -6,391	-6%	-$3.66M	1.89%	15
2024 Q1	$67.1M	Sell	115,375 -4,177	-3%	-$2.34M	1.79%	14
2023 Q4	$63.5M	Sell	119,552 -3,645	-3%	-$1.76M	1.78%	14
2023 Q3	$62.4M	Sell	123,197 -5,652	-4%	-$3.01M	1.94%	15
2023 Q2	$67.3M	Sell	128,849 -13,596	-10%	-$7.34M	1.89%	13
2023 Q1	$82.1M	Sell	142,445 -20,213	-12%	-$11.4M	2.3%	8
2022 Q4	$89.6M	Sell	162,658 -13,553	-8%	-$7.18M	2.42%	4
2022 Q3	$89.4M	Sell	176,211 -167,782	-49%	-$93.9M	2.66%	5
2022 Q2	$187M	Sell	343,993 -20,665	-6%	-$11.4M	3.12%	2
2022 Q1	$216M	Sell	364,658 -29,185	-7%	-$16.8M	2.92%	2
2021 Q4	$263M	Buy	+393,843	New	+$246M	3.26%	2